Abstract
SUMMARY: High-resolution MR imaging of peripheral nerves is becoming more common and practical with the increasing availability of 3T magnets. There are multiple reports of MR imaging of peripheral nerves in compression and entrapment neuropathies. However, there is a relative paucity of literature on MRN appearance of diffuse peripheral nerve lesions. We attempted to highlight the salient imaging features of myriad diffuse peripheral nerve disorders and imaging techniques for MRN. Using clinical and pathologically proved relevant examples, we present the MRN appearance of various types of diffuse peripheral nerve lesions, such as traumatic, inflammatory, infectious, hereditary, radiation-induced, neoplastic, and tumor variants.
Abbreviations
- CIDP =
- chronic inflammatory demyelinating polyneuropathy;
- CMT =
- Charcot-Marie-Tooth;
- fat sat =
- fat saturated;
- FLAIR =
- fluid-attenuated inversion recovery;
- FLH =
- fibrolipomatous hamartoma;
- GBS =
- Guillain Barré syndrome;
- CMT/HSMN =
- Charcot-Marie-Tooth/hereditary motor and sensory neuropathy;
- MMN =
- multifocal motor neuropathy;
- MPNST =
- malignant peripheral nerve sheath tumor;
- MRN =
- MR neurography;
- NF1 =
- neurofibromatosis type 1;
- NL =
- neurolymphomatosis;
- SE =
- spin-echo;
- SNR =
- signal-to-noise ratio;
- SPACE =
- sampling perfection with application-optimized contrasts by using different flip angle evolutions;
- SPAIR =
- spectral-attenuated inversion recovery;
- STIR =
- short-tau inversion recovery;
- T1WI =
- T1-weighted imaging;
- T1WIFS =
- T1-weighted fat-saturated imaging;
- T2WI =
- T2-weighted imaging;
- T2WIFS =
- T2-weighted fat-saturated imaging
High-resolution MR imaging of peripheral nerves is becoming more common and practical with increasing availability of 3T magnets. These magnets provide high SNR, which can be used for a quicker acquisition time as well as higher image contrast and resolution. There have been multiple reports of MR imaging of peripheral nerves in compression and entrapment neuropathies.1–3 However, there is a relative paucity of literature on the MRN appearance of diffuse peripheral nerve lesions.4 These lesions seen on MR imaging present a diagnostic dilemma because a long list of pathologies could be causing them. We attempt to highlight the salient imaging features of myriad diffuse peripheral nerve disorders and to describe a diagnostic approach to these lesions on the basis of the available literature and our experience in this area. Various clinical and pathologically proved relevant examples of these pathologies are illustrated.
High-Resolution MRN Technique
MRN techniques can be broadly divided into T2-based imaging or diffusion-based imaging. T2-based MR imaging of peripheral nerves is generally preferred over diffusion-based imaging because radiologists and technologists are more familiar with T2-based imaging; moreover, the techniques and the pulse sequences are easier to implement.5 Diffusion-based imaging of peripheral nerves is still in the research phase due to suboptimal SNR obtained in peripheral nerve imaging and at present has not been widely implemented.6,7 T2-based MRN imaging relies on obtaining high-resolution (2- to 3-mm section thickness) T1WI SE/T1WI FLAIR images and T2WIFS SE/SPAIR/STIR images in multiple planes (Fig 1). The abundant fat around the fascicles and the nerve itself makes these structures clearly visible on T1WI. STIR works best at 1.5T, while SPAIR with varying flip angles is the favored fat-suppression technique for 3T magnets because it provides higher SNR than STIR images.1 T2WIFS may provide inhomogeneous fat suppression, especially for large peripheral areas of the body chosen for evaluation of diffuse nerve lesions. 3D pulse sequences such as SPACE have been reported to perform well at 1.5T and 3T MR imaging (Fig 2 ).8 Multiplanar reconstructions of these 3D sequences allow good depiction of peripheral nerves, which commonly course through a variety of obliquities.
Normal and Abnormal Peripheral Nerves on High-Resolution MRN Imaging
The reader should carefully evaluate various characteristics of peripheral nerves on high-resolution MRN imaging (Table 1), such as size, signal intensity, fascicular pattern (Fig 1), and course (Fig 2). Various imaging criteria are helpful in differentiating a normal peripheral nerve from a diseased nerve (Fig 1).1, 9 Intravenous administration of gadolinium is also helpful in detecting abnormal nerve and denervated muscle enhancement in patients suspected of various inflammatory, infectious, and neoplastic neuropathies.
Etiology of Diffuse Peripheral Nerve Lesions
Diffuse peripheral nerve lesions may be divided into traumatic, inflammatory, infectious, hereditary, radiation-induced, neoplastic, and tumor variants (Table 2). 10–18 Relevant examples of cases from each category with their MRN imaging characteristics are illustrated (Table 3).
Traumatic Neuropathy
Direct trauma to the peripheral nerve may be caused by stretching or laceration during a traumatic event. Other mechanisms of injury include acute or chronic compression related to hematoma, bony fracture, and ischemia and, rarely, intramuscular injections.10 Superficial nerves and fascicles that lie along the periphery of the nerve may be affected more severely in direct trauma, such as greater involvement of the peroneal component of the sciatic nerve by external trauma or compression.19 MRN may not only show the abnormal nerve (Fig 3), thereby confirming the clinical suspicion, but may also demonstrate the underlying causative lesion.
Inflammatory Neuritis
Peripheral nerves may be affected by a variety of inflammatory processes, and the clinically suspected pathologic nerves can be visualized in detail with high-resolution MRN imaging. Brachial plexus neuritis (plexitis) is a common occurrence. It is possibly immune-mediated and inflammatory, as is the form furste of acute GBS.11 The usual presentation is sudden onset of pain, followed by weakness and paraesthesia.20 There have been possible associations with viral or bacterial infection, vaccination, trauma, or surgery. This condition is self-limiting (4–6 weeks), and treatment is conservative. MRN plays a crucial role in its management because it may confirm the diagnosis of brachial plexitis (Fig 4 ) as well as distinguish it from cervical radiculopathy. Surgery is needed for the latter diagnosis. Brachial neuritis involves multiple nerves, unlike the fixed nerve distribution of cervical spondylosis and degenerative disk disease.
CIDP
CIDP is rare and is considered the chronic counterpart of GBS; the peak of illness in GBS is <4 weeks.12,21 The clinical features include a chronic course (>2 months); and proximal and distal muscle weakness with sensory involvement, areflexia, and albuminocytologic dissociation (Figs 5 and 6).
Hereditary Neuropathy
CMT is a rare disease14; it is also known as hereditary motor and sensory neuropathy. A positive family history may be found in as many as 80% of cases.(23) The usual clinical presentation is chronic degeneration of peripheral nerves and roots, with muscle atrophy and sensory impairment in a distal distribution.(15,24) Clinical findings include atrophy and sensory loss affecting all extremities, ataxia, areflexia, palpably enlarged peripheral nerves, pes cavus, and hammer toes. Bilateral lumbosacral plexus and peripheral nerve involvement are common. The enlarged nerves are frequently related to increased fatty interfascicular epineurium with demyelinating atrophic fascicles (Fig 9 ).
Radiation Neuropathy
There may be a long and variable interval (weeks to years) between radiation therapy and the onset of symptoms.(16) It is essentially a diagnosis of exclusion. Neoplastic disease (primary or metastatic), infectious, and other etiologies should be ruled out first (Fig 10 ). The severity is dose-dependent, and radiation neuropathy is seen more commonly with doses of >60 Gy.(25)
Neoplasia and Tumor Variants
A variety of tumors and tumor variants may involve the peripheral nerves. The role of MR imaging has been widely reported and is well-defined in neurofibromatosis (Figs 11 and 12). Multiple signs, such as a bag-of-worms appearance in plexiform neurofibroma, “split fat” sign on T1WI, and target and tail signs on T2WI, have been described.(26,27) Other signs that may help to differentiate malignant from benign nerve sheath tumors are size >5 cm, necrosis or heterogeneous enhancement, and invasion of surrounding structures.(26) NL or lymphomatous infiltration of the peripheral nerves has been reported in ≤40% of patients dying of lymphoma.(18) The typical presentation is progressive sensorimotor neuropathy, and the diagnosis is usually confirmed by a histopathologic examination (nerve biopsy or autopsy) demonstrating lymphomatous infiltration of nerves (Fig 13 ).
Perineuroma is a benign tumor of neoplastic perineural cells (Fig 14 ). It may present as mononeuropathy or plexopathy. Motor symptoms with extensive chronic muscle denervation changes are more commonly seen than sensory symptoms.(28,29) FLH is a rare benign lesion, which has distinctive features on MR imaging.(30,31) The median nerve is affected most commonly; however, it can also be seen at other sites (Fig 15 ). A variety of proteins may be deposited in nerves with systemic amyloidosis, resulting in severe progressive mixed neuropathy and autonomic dysfunction.(17,32) The MR imaging appearance of amyloidosis of nerves has also been described (Fig 16 ).(33)
Summary
Diffuse abnormalities of peripheral nerves may be seen with numerous pathoetiologies. Currently, biopsy and pathologic examination of the nerves remain the only definitive ways of achieving a final diagnosis. However, a high-resolution MRN examination may be used to confirm the clinical suspicion and exclude other etiologies, such as a compressive mass lesion; in the correct clinical setting, it may aid in diagnosis and management of these lesions. Future research is needed to further validate the outlined differentiating MR imaging features of diffusely diseased peripheral nerves.
Footnotes
-
K.C.W. was supported by the Radiological Society of North America Research and Education Foundation Fellowship Training Grant FT0904 and the Walter and Mary Ciceric Research Award.
-
Paper previously presented as an Electronic Scientific Exhibit at: Annual Meeting of the American Society of Neuroradiology, May 15–20, 2010; Boston, Massachusetts.
Indicates open access to non-subscribers at www.ajnr.org
References
- © 2011 by American Journal of Neuroradiology